TP53 and cancer: Vaccination aimed at increasing cellular immunity against p53-contained cancer cells was initiated in the 1990s [171], and the concept of p53 mRNA vaccine has been revived in recent years as a result of the inspiring results of mRNA vaccination in the coronavirus disease 2019 (COVID-19) pandemic.